Skip to main content
. 2024 Sep 26;2024(9):CD006689. doi: 10.1002/14651858.CD006689.pub3

3.17. Analysis.

3.17

Comparison 3: Dihydroartemisinin‐piperaquine (DHA‐PPQ) plus daily cotrimoxazole (CTXp) versus placebo plus CTXp, Outcome 17: Congenital malformations